Cargando…
Rebleeding after Initial Endoscopic Hemostasis in Peptic Ulcer Disease
Endoscopic hemostasis is the first-line treatment for upper gastrointestinal bleeding (UGIB). Although several factors are known to be risk factors for rebleeding, little is known about the use of antithrombotics. We tried to verify whether the use of antithrombotics affects rebleeding rate after a...
Autores principales: | Hong, Mi Jin, Lee, Sun-Young, Kim, Jeong Hwan, Sung, In-Kyung, Park, Hyung Seok, Shim, Chan Sup, Jin, Choon Jo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214943/ https://www.ncbi.nlm.nih.gov/pubmed/25368496 http://dx.doi.org/10.3346/jkms.2014.29.10.1411 |
Ejemplares similares
-
Factors Associated with Rebleeding in Patients with Peptic Ulcer Bleeding: Analysis of the Korean Peptic Ulcer Bleeding (K-PUB) Study
por: Kim, Joon Sung, et al.
Publicado: (2018) -
Nomogram for predicting rebleeding after initial endoscopic epinephrine injection monotherapy hemostasis in patients with peptic ulcer bleeding: a retrospective cohort study
por: He, Shan, et al.
Publicado: (2022) -
Development and validation of a model to predict rebleeding within three days after endoscopic hemostasis for high-risk peptic ulcer bleeding
por: Lai, Yongkang, et al.
Publicado: (2022) -
Risk Factors for the Presence of Symptoms in Peptic Ulcer Disease
por: Lee, Sang Pyo, et al.
Publicado: (2017) -
Pantoprazole for the Treatment of Peptic Ulcer Bleeding and Prevention of Rebleeding
por: van Rensburg, Christo J., et al.
Publicado: (2012)